Phuong N. Huynh

Array ( [id] => 9019922 [patent_doc_number] => 08529905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Soluble inhibitors of vascular endothelial growth factor and use thereof' [patent_app_type] => utility [patent_app_number] => 12/756737 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 40 [patent_no_of_words] => 17755 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9099116 [patent_doc_number] => 08562988 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-22 [patent_title] => 'Strategies for improved cancer vaccines' [patent_app_type] => utility [patent_app_number] => 12/754740 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 27620 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12754740 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6468602 [patent_doc_number] => 20100190964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Antibodies to human ErbB4' [patent_app_type] => utility [patent_app_number] => 12/753792 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29384 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190964.pdf [firstpage_image] =>[orig_patent_app_number] => 12753792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502320 [patent_doc_number] => 08034352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Tetrameric cytokines with improved biological activity' [patent_app_type] => utility [patent_app_number] => 12/752649 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24346 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 196 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034352.pdf [firstpage_image] =>[orig_patent_app_number] => 12752649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6529905 [patent_doc_number] => 20100221210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo' [patent_app_type] => utility [patent_app_number] => 12/731781 [patent_app_country] => US [patent_app_date] => 2010-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20357 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221210.pdf [firstpage_image] =>[orig_patent_app_number] => 12731781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158437 [patent_doc_number] => 20120100141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'DRUG FUSIONS AND CONJUGATES' [patent_app_type] => utility [patent_app_number] => 13/256957 [patent_app_country] => US [patent_app_date] => 2010-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 24974 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100141.pdf [firstpage_image] =>[orig_patent_app_number] => 13256957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6270814 [patent_doc_number] => 20100254999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/724964 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 42869 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254999.pdf [firstpage_image] =>[orig_patent_app_number] => 12724964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702627 [patent_doc_number] => 08088380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/724386 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 53571 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088380.pdf [firstpage_image] =>[orig_patent_app_number] => 12724386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11751554 [patent_doc_number] => 09709563 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Passivation of surfaces after ligand coupling' [patent_app_type] => utility [patent_app_number] => 12/723458 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10864 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12723458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301004 [patent_doc_number] => 20120183562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'SECRETED FXYD PROTEINS EXPRESSED IN RESPONSE TO EPITHELIAL TISSUE DAMAGE, AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/203193 [patent_app_country] => US [patent_app_date] => 2010-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9029 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13203193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500489 [patent_doc_number] => 20100215676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'KDR PEPTIDES AND VACCINES COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/711159 [patent_app_country] => US [patent_app_date] => 2010-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 13028 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215676.pdf [firstpage_image] =>[orig_patent_app_number] => 12711159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234782 [patent_doc_number] => 20100186100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'ANTIBODIES AND PEPTIDE ANTIGENS FOR PRODUCING ANTIBODIES HAVING A SELECTIVE BINDING SPECIFICITY TO BIOACTIVE INTACT PARATHYROID HORMONE (PTH) 1-84' [patent_app_type] => utility [patent_app_number] => 12/709103 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5003 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20100186100.pdf [firstpage_image] =>[orig_patent_app_number] => 12709103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277075 [patent_doc_number] => 09493551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Antibodies containing therapeutic TPO/EPO mimetic peptides' [patent_app_type] => utility [patent_app_number] => 13/202932 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25420 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320517 [patent_doc_number] => 20100196376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHOD FOR REDUCING ALLERGEN-INDUCED AIRWAY HYPERRESPONSIVENESS' [patent_app_type] => utility [patent_app_number] => 12/703667 [patent_app_country] => US [patent_app_date] => 2010-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22804 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196376.pdf [firstpage_image] =>[orig_patent_app_number] => 12703667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7818953 [patent_doc_number] => 20120065573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Methods of Treating Vascular Lesions' [patent_app_type] => utility [patent_app_number] => 13/147844 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7963 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065573.pdf [firstpage_image] =>[orig_patent_app_number] => 13147844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454510 [patent_doc_number] => 20100189719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/700609 [patent_app_country] => US [patent_app_date] => 2010-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 53303 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189719.pdf [firstpage_image] =>[orig_patent_app_number] => 12700609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016843 [patent_doc_number] => 08137923 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Glycoprotein VI and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/690710 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 35 [patent_no_of_words] => 52721 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137923.pdf [firstpage_image] =>[orig_patent_app_number] => 12690710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280355 [patent_doc_number] => 20100119509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE DEVELOPMENT OF RHEUMATOID ARTHRITIS' [patent_app_type] => utility [patent_app_number] => 12/686415 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 112 [patent_figures_cnt] => 112 [patent_no_of_words] => 13697 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119509.pdf [firstpage_image] =>[orig_patent_app_number] => 12686415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6453292 [patent_doc_number] => 20100189651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 12/686344 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 50475 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189651.pdf [firstpage_image] =>[orig_patent_app_number] => 12686344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6530747 [patent_doc_number] => 20100221254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Methods and Compositions for PDGF-C Activation and Inhibition' [patent_app_type] => utility [patent_app_number] => 12/652998 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15517 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221254.pdf [firstpage_image] =>[orig_patent_app_number] => 12652998 [rel_patent_id] =>[rel_patent_doc_number] =>)